Dr. Panos Z. Marmarelis, MD, PhD

Dr. Marmarelis practices at Neuromedical Diagnostic Medical Group in Long Beach, California.

Dr. Marmarelis' NPI, 1275585622, was assigned on May 16, 2006. Dr. Marmarelis graduated from University of Miami, Miller School of Medicine in 1977. Dr. Marmarelis holds California license G37550.

Dr. Marmarelis' primary practice is Neuromedical Diagnostic Medical Group, at 1045 Atlantic Ave, Long Beach, CA 90813 in Los Angeles County. The practice phone is (562) 591-1324.

Dr. Marmarelis' primary practice is Neuromedical Diagnostic Medical Group in Long Beach, California. The medical group on file is NeuroMedical Diagnostic Group. Dmand AI also links Dr. Marmarelis to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marmarelis practices. Vendor and product names are available with a free account.

Neurology is Dr. Marmarelis' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Marmarelis is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Marmarelis is licensed in California.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Dr. Marmarelis treats.

CMS data shows 2,557 Medicare services from Dr. Marmarelis across 11 procedure codes in 2024, for 657 Medicare patients. Medicare paid $280,220 for them. Every service was in an office.

CMS counts 657 Medicare patients who saw Dr. Marmarelis in 2024. The largest group is 65 to 74, with 233 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marmarelis' median patient age at 67, with 59% women.

In 2024, Dr. Marmarelis wrote 1,588 Medicare Part D claims for 177 patients. 99% of them were for generic drugs. CMS names the drug for 1,421 of them, across 33 drugs with 11 or more claims each, at $24,782 in total drug cost. In 2023, CMS named 1,164 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Marmarelis for performance year 2024, reported as part of a group. Dr. Marmarelis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marmarelis as offering telehealth.

Dmand AI links 9 papers to Dr. Marmarelis. The most frequent topics are Fishes, Retina and Evoked Potentials. Dr. Marmarelis has published most often in J Neurophysiol. Dr. Marmarelis' most frequent co-author is Mark Christopher Asbill, MD.

CMS Open Payments shows 31 general payments to Dr. Marmarelis from 12 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $237.

Dmand AI lists 1 award for Dr. Marmarelis, most recently CMS Stage 1 EHR in 2013.

Dr. Marmarelis graduated from University of Miami, Miller School of Medicine in 1977.

Dr. Marmarelis is in network with 15 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.